PSEUDOMONAS AERUGINOSA INFECTION
Clinical trials for PSEUDOMONAS AERUGINOSA INFECTION explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA INFECTION trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody tackles stubborn biofilms in cystic fibrosis lungs
Disease control CompletedThis study tested a single dose of CMTX-101, an antibody designed to break up bacterial biofilms, in 43 adults with cystic fibrosis who have chronic lung infections with Pseudomonas aeruginosa. The goal was to see if adding CMTX-101 to standard inhaled antibiotics is safe and tol…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Clarametyx Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for lung infection sufferers: inhaled antibiotic trial shows promise
Disease control CompletedThis study tested whether an inhaled antibiotic (tobramycin), taken alone or with an oral antibiotic (ciprofloxacin), can permanently clear Pseudomonas aeruginosa infections from the lungs of people with bronchiectasis. The trial involved 371 adults and compared these treatments …
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE4 • Sponsor: Jin-Fu Xu • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New biosensors aim to diagnose infections in minutes
Diagnosis CompletedThis study tested two new types of biosensor platforms to detect viruses, bacteria, and parasites in blood and respiratory samples. The goal was to see if these devices could be accurate, fast, and cheap alternatives to standard lab tests. Researchers enrolled 149 adults with or …
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Sponsor: University of Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC